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Abstract
Project Aims
- Develop a set of recommended measures for routine use in the assessment, diagnosis, screening and
outcomes monitoring of dementia conditions and the evaluation of treatments that are applicable for the
Australian health care context.
- Standardise the assessment and evaluation procedures used in this field to enhance comparability of
findings across research and practice settings.
- Make recommendations concerning the clarification and standardization of the clinical terminology
applicable in this field.

Keywords
lecture, guest, tools, suite, measurement, improvement, outcomes, practice, series, dementia

Publication Details
J. Sansoni, N. Marosszeky & E. Sansoni "The Dementia Outcomes Measurement Suite: tools for practice
improvement (Guest lecture series)", Eastern Australia Dementia Training and Study Centre (EADTSC),
University of Wollongong, 19 Aug, (2008)

This conference paper is available at Research Online: https://ro.uow.edu.au/ahsri/342

The Dementia Outcomes
Measurement Suite: Tools for
Practice Improvement
Jan Sansoni, Nick Marosszeky,
Emily Sansoni

CHSD

Centre for Health Service Development

Project Aims
 Develop a set of recommended measures for
routine use in the assessment, diagnosis,
screening and outcomes monitoring of dementia
conditions and the evaluation of treatments that
are applicable for the Australian health care
context.
 Standardise the assessment and evaluation
procedures used in this field to enhance
comparability of findings across research and
practice settings.
 Make recommendations concerning the
clarification and standardization of the clinical
terminology applicable in this field.
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Why Outcomes Monitoring?
• More common in research applications and
pharmaceutical evaluation – not common in
routine practice
• How do we know whether our interventions work
unless we evaluate them?
• Do we know whether our routine care practices
are delivering acceptable outcomes to our
clients?
• Objectives – maintenance of function; slowing in
the rate of deterioration
3

Project Team: Principal Investigators
 Ms Jan Sansoni (Project Manager)
 Assoc Prof Marc Budge (Senior Clinical Advisor)
 Prof Lynn Chenoweth (clinical, dementia, BPSD
and cognitive)
 A/Prof Graeme Hawthorne (utility, social isolation,
patient & carer satisfaction)
 Dr Madeleine King (HRQOL, cognitive, BPSD)
 Dr Yun-Hee Jeon (clinical, dementia, BPSD and
cognitive)
 Mr Nick Marosszeky (all – function, CALD, Proxy)
4

Associate Investigators
• Ms Siggi Zapart, CHERE (Instrument Reviews)
• Ms Emily Sansoni, AHOC/CHSD (Instrument
Reviews; Editing)
• Dr Kate Senior, CDU (Indigenous Health)
• Ms Patsy Kenny, CHERE (Carer Burden)
• Dr Lee-Fay Low, UNSW (Instrument Reviews)
Project
Advised by National Expert Group for Dementia
Advised by Expert Measurement Group
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Categories of Instrument Review
•
•
•
•
•

Dementia Staging and Descriptive Instruments
Health-Related Quality of Life
Cognition
Social Isolation
Associated Behavioural and Mental Symptoms
(BPSD; Delirium; Individual Symptoms)
• Functioning
• Economic Utility
• Patient and Carer Satisfaction
6

Review Processes
 Initial overall literature search (MEDLINE,
PsycINFO) on 20 terms (e.g. dementia, cognition,
memory, function, Qol etc)
 Examined major texts in the field (e.g.
psychometric review texts, Burns, Kane & Kane,
Lezak, McKeith etc)
 Identified list of instrument categories and names
and then searched on these names
 Developed database with comparative data for
instruments in each category
 Developed CD containing papers and abstracts
for each category of instruments
7

Review Processes
 Developed an impact sheet for the EMG and the
review team – Medline, text and web impacts,
presence in instrument databases, use in clinical
practice (based on field surveys, NEP and clinical
feedback)
 Identified a shortlist of about 12 leading contender
instruments for each category
 Categories: Dementia staging and descriptive
instruments, Cognitive, Associated symptoms (e.g.
BPSD; delirium; individual symptoms e.g. apathy),
Function, HRQOL, Multi-attribute utility measures,
Social isolation, Patient and carer satisfaction)
8

Review Processes
 Applied additional criteria to reduce to 5-6
instruments per category
 Produced decision summary sheet justifying
selection or non selection of contenders for the
short list
 Undertook more extensive searches for short-listed
instruments e.g. other databases – CINAHL,
Cochrane etc and commenced review
9

Additional Selection Criteria
 Whether there is a copy of the instrument and the
original article available for review
 The number of citations found (save new
instruments)
 The amount and range of the published
psychometric evidence
 Whether the instrument used in clinical practice
(searches, surveys) & applicability to Australian
context
 Availability of normative and clinical reference data
10

Additional Selection Criteria
 Administration time (< 30 minutes and shorter
preferred)
 Applicability for patients / clients with varying
levels of severity of dementia.
 Proprietary considerations (e.g. prohibitive cost)
 Applicability for use in routine care – does not
require specialist skills for administration (e.g. as
for many neuropsychological/medical
assessments)

11

AHOC Review Sheet










Author, publication information, availability
Cost
Training requirements
Purpose & who developed for
Administration time
Structure
Scoring
Applications, normative and clinical reference data
Psychometric criteria –reliability, validity,
responsiveness
 Cultural applicability and cultural adaptations
 Gender and age appropriateness
12

Review of Instruments
With all instruments we considered
 Type and stages of dementia
 Purpose of instrument (assessment, screening,
outcomes monitoring and evaluation of
interventions)
 Self-reporting and proxy reporting
 Respondent and staff burden
 Appropriateness for CALD and indigenous groups
 Appropriateness for setting (e.g. acute, primary,
community and residential care; specialist;
research)
13

Instrument Scores and Weights











Availability of comparison data (3)
Length/feasibility (2)
Complexity of administration / cognitive burden (3)
Ease of obtaining score (2)
Cultural Appropriateness (1)
Sensitivity to dementia (3)
Reliability evidence (3)
Validity evidence (3)
Cost of instrument (2)
Cost of instrument administration (2)

Scores: generally 1 = poor, 2 = moderate 3 = good
– refer to detail in the paper
Multiply the score by the weight and then sum to get a
total instrument score
14

Example: Cognitive Assessment
 93 instruments identified
 Abbreviated Mental Test ,Addenbrookes, ADAS,
Blessed IMC Test, Cambridge Cog, Cambridge
Mental Disorders, Cog. Capacity Screen, Cog.
Abilities Screen, Clock Drawing, Geriatric Mental
State, GP Cog, Informant Q on Cog, KICA-Cog,
Mattis DRS, Mini Cog MMSE, Memory Impairment
Screen, Mental Status Q, RUDAS, and Short
Portable Mental amongst contenders
 Proprietary issues some instruments – e.g. some
forms of MMSE
 Excluded neuropsychological specialist instruments
(focus is routine care)
15

MMSE ADAS GPCOG
3MS
COG

RUDAS MDS

Cognitive
Assessment

W

Avail. comparison
data

3

3

2

1

1

1

1

Length

Cultural app.

2
2
1

2
2
2

1
2
3

3
3
1

3
2
3

3
3
1

2
2
3

Ease: scoring

2

3

3

3

3

3

3

Sensitivity
Dementia

3

3

3

2

2

2

2

Reliability
Validity

3
3

3
3

3
3

3
3

3
3

2
3

2
1.5

Cost

2

3

3

3

1

2

3

Cost of admin

2

2

1

1

2

2

2

62

56

54

52

51

46.5

Complex. admin

Weighted Total

COG

KICA
COG
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Recommendations: Cognitive
 The instruments with the highest scores were the
MMSE-3MS and the ADAS-Cog
 3MS was selected from the MMSE family for
routine settings; better psychometrics and less
proprietary issues
 ADAS-Cog may be preferred if more in depth
assessment required (e.g. clinical research)
 GP-Cog most appropriate for primary care
 MDS-Cog can also be considered for residential
care settings
 RUDAS (Interim) for CALD and…
 Kimberley Indigenous Cognitive Assessment
(Interim) for Indigenous
17

Descriptive and Staging Measures
Five instruments were selected for comprehensive
review from twelve contender measures:
 Blessed Dementia Rating Scale (BDS)
 Clinical Dementia Rating Scale (CDR)
 Dementia Severity Rating Scale (DSRS)
 Global Deterioration Scale (GDS)
 Sandoz Clinical Assessment for Geriatric
(SCAG)
These descriptive instruments are useful in
providing a common language concerning
severity and stage of dementia
18

Staging &
Descriptive

W

Avail. comparison
data

3

2.5

2.5

1.5

2

2

Length

Cultural app.

2
2
1

3
3
2

1
2
3

3
3
2

1
2
2

2
3
2

Ease: scoring

2

3

3

2

3

3

Sensitivity
Dementia

3

2

3

2

3

2

Reliability
Validity

3
3

3
3

3
3

3
3

2
3

2
2

Cost

2

3

3

3

3

3

Cost of admin.

2

2

1

2

2

2

56.5

52

50

Complex. admin

Weighted Total

GDS CDRS

61.5 57.5

DSRS

Blessed Sandoz
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Descriptive and Staging Measures
Recommendations:
 Global Deterioration Scale (GDS) / Functional
Assessment Staging (FAST) – ease of use
 Clinical Dementia Rating (CDR)- more
comprehensive –second stage of assessment
 The Dementia Severity Rating Scale (DSRS)
(Proxy application in community settings –
caregiver rating scale)

20

Example: Dementia-HRQOL
 Seven leading dementia – HRQOL contenders
identified
 QOL-AD, QUALID, DEMQOL were chosen for in
depth review. Proxy versions were also available
for these instruments. (DQOL a runner up)
 Preferred instruments were the QOL-AD and the
DEMQOL for mild to moderate dementia and the
QUALID for late stage dementia
 Australian reference data required for all
instruments

21

HRQOL
Dementia

W

Avail. comparison
data

3

2

2

2

2

1

2

Length

Cultural app.

2
2
1

3
3
2

2
3
1

3
3
2

2
3
1

2
3
1

1
3
2

Ease: scoring

2

2

2

2

2

2

1

Sensitivity
Dementia

3

3

3

2

2

2

2

Reliability
Validity

3
3

3
3

3
3

3
3

3
3

3
3

3
3

Cost

2

3

2

2

2

3

1

Cost of admin.

2

2

2

2

2

1

2

61

56

56

53

50

48

Complex. admin

Weighted Total

QOL DEM
-AD QOL

QUALID DQOL CBS

ADR
QOL
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HRQOL Measures: Generic
 Also examined generic HRQOL instruments re
their applicability for use with people with
dementia (e.g. global indices, Dartmouth
COOP, SF-12V2 & SF36V2, WHOQOL-OLD,
SIP, NHP etc.).
 The review concluded that most instruments
are not appropriate for use with moderate to
severe dementia patients as they involve selfrating or contain inappropriate/complex items
particularly for those in residential care. Many
are too long.
23

HRQOL Measures: Generic
 A chapter reviews the leading contenders
and discusses key issues concerning the
cognitive capacity required to self-rate and
the use of proxies.
 It is most likely these generic instruments
would be used with dementia carers to
assess their HRQOL rather than with
dementia patients per se.
24

Behavioural and Psychological
Symptoms of Dementia






Neuropsychiatric Inventory (NPI)
Behavioural Pathology in Alzheimer’s Disease
Rating Scale (BEHAVE-AD)
Consortium to Establish a Registry for
Alzheimer’s Disease – Behaviour Rating Scale
for Dementia (CERAD-BRSD) (research only until the shortened version is available and
assessed)
The Dementia Behaviour Disturbance Scale
and the Neurological Rating Scale were not
preferred
25

Global
BPSD

W

NPI

Avail. comparison
data

3

2

2

2.5

1

2

Length

Cultural app.

2
2
1

3
3
3

2
3
3

1
2
2

2
2
2

2
1
2

Ease: scoring

2

3

3

3

3

3

Sensitivity Dementia

3

3

3

3

2

2

Reliability
Validity

3
3

3
3

3
3

3
3

3
2

3
2

Cost

2

3

3

1

2

2

Cost of admin.

2

2

2

2

2

1

64

62

54.5

50

26
49

Complex. admin

Weighted Total

BEHAVE
-AD

CERAD
-BRSD

DBDS

NRS

Delirium
 Confusion Assessment Method (CAM) –
simpler with superior utility but does not capture
severity of symptoms and hence cannot be
used for repeated measures of delirium severity
 Delirium Rating Scale (DRS-R-98) - more
comprehensive as assesses both the presence
and severity of symptoms; requires training and
a 24 hour observation period
27

Individual Symptoms
 Rating Scale for Aggression in the Elderly
(RAGE)
 Cohen Mansfield Agitation Inventory (CMAI)
and Pittsburgh Agitation Inventory (PAI)
 Rating Anxiety in Dementia (RAID)
 Apathy Evaluation Scale (AES)
 Cornell Scale for Depression in Dementia
(CSDD) and Geriatric Depression Scale (GDS) –
the latter for community settings
28

Function
 Function instruments can be ADL, IADL or a
combination of these. They can also be
generic or dementia specific measures.
 19 instruments examined were reduced to a
short-list of 12 instruments and the following
instruments were recommended
Function Generic:
 FIM (ADL) – acute and residential
 Barthel (ADL) – community
 OARS-IADL – adapted for primary and community
care in Australia
29

Function
Function & Dementia:
 Alzheimer’s Disease Cooperative StudyADL (proxy report)
 Disability Assessment for Dementia (proxy
report)
 Cleveland Scale-ADL (observation; acute
and residential)
30

Issues: Function
• Absence of research consensus for
measurement of function in dementia
• High degree of overlap between items – need
for streamlining
• Item Response Theory could be used to cross
calibrate items from the recommended
measures
• Could then examine item redundancy and
coverage across the range of severity levels to
develop better tools
31

Social Function
Focus of measurement falls into 2 categories
 Social participation, networks, support, social
contact (sometimes includes ‘objective’ items
such as no. of social contacts)
 Social isolation, loneliness (satisfaction with
social contacts or feelings of loneliness)
 The MOS Social Support Survey is a blend

Fifteen instruments were identified and seven
were selected for detailed examination
32

Social Function
 Recommendations:
 Social participation, networks, support, social
contact (no instruments recommended;
problems with instrument and item design;
need for further research)
 Social isolation, loneliness (De Jong Gierveld
Loneliness Scale, Friendship Scale)
 The top performer was the De Jong Gierveld
Loneliness Scale but it requires linguistic
adaptation to its response categories (Yes! Yes).
The MOS and the Friendship Scale were runners
up.
33

Multi-attribute Utility Measures
 MAU measures are largely used for economic
evaluation and are also known as health indexes
 The permutations and combinations of responses
to a number of questions about health generate
numerous ‘health states’ which can be rated on a
scale from 0-1
 By this method we can derive one total health
score (e.g. 0.60 for a health state) and thus can
compare the valuations for different health
conditions (burden) and of the effect of different
treatments on a condition

34

EuroQol EQ-5D
•

•

•

•

•

Score type = 1,1,1,2,3
= health state

MOBILITY
– I have no problems in walking about
– I have some problems in walking about
– I am confined to bed
SELF-CARE
– I have no problems with self-care
– I have some problems washing or dressing myself
– I am unable to wash or dress myself
USUAL ACTIVITIES (e.g. work, study, housework, family or
leisure activities)
– I have no problems with performing my usual activities
– I have some problems with performing my usual activities
– I am unable to perform my usual activities
PAIN/ DISCOMFORT
– I have no pain or discomfort
– I have moderate pain or discomfort
– I have extreme pain or discomfort
ANXIETY/ DEPRESSION
– I am not anxious or depressed
– I am moderately anxious or depressed
– I am extremely anxious or depressed
35

MAU Instruments for Economic
Evaluation
 Multi-attribute utility measures (MAU) such as the
EQ-5D (5 items) and the AQol (12 items) are
preferred when undertaking economic evaluations
 Both instruments require adaptation – EQ-5D has
scoring distribution & scoring algorithm issues
and the AQoL requires shortening
 There are issues of self-report/cognitive burden
and proxy assessment for these instruments
36

Patient Satisfaction
Theories of patient satisfaction suggest instruments
should cover 7 areas:
 Access to health services and the treatment
environment;
 Provision of health information;
 The relationship with care providers;
 Participation in making health care choices;
 The technical quality of care;
 Treatment effectiveness (helping the daily life of the
patient); and
 General satisfaction
Patient dissatisfaction occurs where there are multiple
transgressions or catastrophic failure in one area.37

Patient Satisfaction
 Eleven instruments and single item assessments
were selected for review. Measures were also
assessed for their coverage of the dimensions of
patient satisfaction
 Generic Measures: Short Assessment of Patient
Satisfaction (SAPS – a 7 item generic measure
developed for the National Continence
Management Strategy) and the Consultation
Satisfaction Questionnaire were the standout out
measures
 No self report dementia specific patient
satisfaction measures were identified
38

The Construction of the SAPS
Final model of a unidimensional Short Assessment of Patient Satisfaction scale (SAPS)
Dimension

N

Item stem (abbreviated)

Item source

Effectiveness

1

Happy with the effect of your treatment

GUTSS

Information

2

Satisfaction with explanations of treatment results

GUTSS

Technical skill

3

The clinician was careful to check everything

Consult SQ

Participation

4

Satisfaction with health care choices

PSI

Relationship

5

How much were you respected

PSI

Access & facilities

6

The time with the clinician was not long enough

Consult SQ

Satisfaction general

7

Happy with the care received

GUTSS

39

Patient Satisfaction
 The 7 item SAPS has an excellent coverage of
the dimensions of patient satisfaction (e.g. the
best) and was the recommended instrument
 SAPS is the shortest PS instrument and has
excellent psychometric properties
 Psychometric evidence indicates that SAPS is a
strong uni-dimensional scale
 SAPS needs to be further tested and validated
with dementia samples (e.g. patients and carers)
40

Single Items: Patient Satisfaction
 Two single item patient satisfaction measures
showed promise from prior continence research
– How satisfied are you with the outcomes of
your treatment?
– How satisfied are you with the amount of help
received?
 These need to be tested with samples of people
with dementia and their carers
 Need for a single item measure for routine use
41

Carer Satisfaction
 Six measures examined – most were generic
measures with poor to weak psychometric
properties
 The Satisfaction with Care at the End of Life in
Dementia Scale was the only dementia specific
measure and was the most promising instrument
 An Australian study is required to further test its
measurement properties
 Examination of carer burden, carer appraisal and
carer wellbeing were outside the scope of this
project
42

Proxy Issues: Definition
“Proxy data refer to those collected from
someone who speaks for a patient who cannot,
will not, or is unavailable to speak for him or
herself, whereas we use the term other-rater
data to refer to situations in which the researcher
collects ratings from a person other than the
patient to gain multiple perspectives on the
assessed construct.” (Snow, et al. 2005a)

43

Proxy Issues
 Proxy reports seen as complementary to patient
self-reports, especially when it is not possible or
feasible to assess a patient with severe dementia
 Need to be aware of Content issues:
 More objective constructs easier and more
accurate to rate than subjective constructs (e.g.
physical symptoms vs. depressive symptoms).
There is more agreement between carer and
patient ratings for the more objective/observable
constructs
44

Proxy Issues
 Need to be aware of Methodological issues:





Cognitive status of proxy
Health status of proxy
Level of caregiver burden
Usually a trade-off between those in close contact with
the patient and those with more clinical training
 Should be based on usual behaviour rather than
extreme behaviour

 Need to be aware of biases and limitations when
using proxy ratings (e.g. socially desirable
responding, negative information over positive
information, filtering)
45

Indigenous Issues
• Senior with regard to remote communities noted
– a general reluctance to talk about mental
health issues and a high level of community
anxiety about people who exhibit symptoms
• Stigma was associated both with the outward
display of symptoms (e.g. aggressive and
unpredictable behaviour) and beliefs about
causation e.g. sorcery

46

Indigenous Issues: Assessment
 Difficulty in using measures developed for Western
populations particularly in rural/remote communities
 Problems with instruments include:
¾ Concepts of functioning being related to career and
employment.
¾ Concepts of independence as being a positive value
(rather than valuing the level dependence an individual
may have on their family).
¾ Measures that include concepts of time (last week, last
year) and also volume (a lot, a little).
¾ Examples that may have little meaning, especially in a
remote context (solving financial affairs, remembering the
name of the high school from which they graduated). 47

Indigenous Issues: Assessment
 Cognitive tests – barriers for those with limited
education, numeracy and literacy.
 Inappropriate questions – name of monarch; day of
week; month of year.
 Even RUDAS judgement item – refers to crossing busy
streets, traffic lights.
 For these reasons KICA-Cog was preferred but it needs
further assessment of its psychometric properties.
 Appendix 14 provides numerous examples of problem
items.
 Recommended measures need to be assessed with
Indigenous populations.
48

Some Identified Research Gaps
 Need for further research to assess the point at
which people can no longer self-rate (e.g. MMSE
score) under different modes of administration
(e.g. self report, interview, interview assisted) for
each instrument
 Some measures need pilot testing in Australia to
obtain reference data (e.g. HRQOL)
 Some of the newer measures (GPCOG, RUDAS,
KICA-COG, SAPS) need further psychometric
data
 Need for further research to streamline measures
of function
49

Some Identified Research Gaps
 Social function/ social support areas may need
follow up research if we wish to focus on more than
just social isolation
 Further research required to address identified
problems with Multi-attribute Utility measures: AQoL
(shorten) and/or EQ-5D (scoring and distribution
issues)
 Carer satisfaction is addressed in this project but
not other informal care measures – this will require
a follow up project
 CALD and ATSI applicability of instruments needs
50
further research

Implementation Issues
 Mandating measures – not recommended
 The report provides a guide to the use of
recommended instruments with regard to stages
of assessment and settings for assessment
 Training Issues – audit curricula, develop certified
modules
 A Dissemination Strategy (e.g. toolkit, brochures,
workshops, videos, papers etc) is needed!
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 Citation: Sansoni J, Marosszeky N, Jeon Y,
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Zapart S, Sansoni E, Senior K, Kenny P, Low L
(2007) Final Report: Dementia Outcomes
Measurement Suite Project. Centre for Health
Service Development, University of Wollongong.
 Report available shortly via
jan.sansoni@bigpond.com
52

